(Q39206078)

10 September 2017

Plasma von Willebrand factor levels predict in-hospital survival in patients with acute-on-chronic liver failure (English)

1 reference

10 September 2017

9

Elwyn Elias

1 reference

10 September 2017

K S Prasanna

1

1 reference

10 September 2017

Ashish Goel

2

1 reference

10 September 2017

G Jayakumar Amirtharaj

3

1 reference

10 September 2017

Anup Ramachandran

4

1 reference

10 September 2017

K A Balasubramanian

5

1 reference

10 September 2017

Ian Mackie

6

1 reference

10 September 2017

Uday Zachariah

7

1 reference

10 September 2017

K G Sajith

8

1 reference

10 September 2017

C E Eapen

10

1 reference

10 September 2017

language of work or name

English

0 references

publication date

8 November 2016

1 reference

Indian Journal of Gastroenterology

10 September 2017

1 reference

10 September 2017

35

1 reference

10 September 2017

6

1 reference

10 September 2017

432-440

1 reference

https://scigraph.springernature.com/pub.10.1007/s12664-016-0708-2

10 September 2017

0 references

cites work

Acute-on chronic liver failure.

1 reference

https://api.crossref.org/works/10.1007%2FS12664-016-0708-2

Acute kidney injury and acute-on-chronic liver failure classifications in prognosis assessment of patients with acute decompensation of cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-016-0708-2

Survival in infection-related acute-on-chronic liver failure is defined by extrahepatic organ failures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-016-0708-2

Characterization of acute-on-chronic liver failure and prediction of mortality in Asian patients with active alcoholism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-016-0708-2

Microvascular thrombosis and multiple organ dysfunction syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-016-0708-2

VWF excess and ADAMTS13 deficiency: a unifying pathomechanism linking inflammation to thrombosis in DIC, malaria, and TTP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-016-0708-2

Von Willebrand Factor as a new marker for non-invasive assessment of liver fibrosis and cirrhosis in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-016-0708-2

von Willebrand factor as new noninvasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-016-0708-2

Imbalance of von Willebrand factor and its cleaving protease ADAMTS13 during systemic inflammation superimposed on advanced cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-016-0708-2

Potential role of ADAMTS13 in the progression of alcoholic hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-016-0708-2

Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-016-0708-2

American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference definitions of the systemic inflammatory response syndrome and allied disorders in relation to critically injured patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-016-0708-2

Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-016-0708-2

Changes in von Willebrand factor-cleaving protease (ADAMTS13) activity after infusion of desmopressin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-016-0708-2

Idiopathic noncirrhotic intrahepatic portal hypertension is associated with sustained ADAMTS13 Deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-016-0708-2

Idiopathic Non-Cirrhotic Intrahepatic Portal Hypertension (NCIPH)-Newer Insights into Pathogenesis and Emerging Newer Treatment Options

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-016-0708-2

N-acetylcysteine reduces the size and activity of von Willebrand factor in human plasma and mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-016-0708-2

Prognostic significance of von willebrand factor in cirrhosis: a possible mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-016-0708-2

Syndromes of thrombotic microangiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-016-0708-2

Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-016-0708-2

Clearance of fibrinogen and von Willebrand factor in serial double-filtration plasmapheresis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-016-0708-2

Therapeutic apheresis: use of human serum albumin, fresh frozen plasma and cryosupernatant plasma in therapeutic plasma exchange

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-016-0708-2

Primary and Secondary Thrombotic Microangiopathy Referred to a Single Plasma Exchange Center for Suspected Thrombotic Thrombocytopenic Purpura: 2000-2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-016-0708-2

Effect of plasma exchange on plasma ADAMTS13 metalloprotease activity, inhibitor level, and clinical outcome in patients with idiopathic and nonidiopathic thrombotic thrombocytopenic purpura.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-016-0708-2

Dengue Virus Infection Triggering Thrombotic Thrombocytopenic Purpura in Pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-016-0708-2

Prediction value of model for end-stage liver disease scoring system on prognosis in patients with acute-on-chronic hepatitis B liver failure after plasma exchange and lamivudine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-016-0708-2

The effect of plasma exchange on entecavir-treated chronic hepatitis B patients with hepatic de-compensation and acute-on-chronic liver failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-016-0708-2

Artificial liver support system improves short- and long-term outcomes of patients with HBV-associated acute-on-chronic liver failure: a single-center experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-016-0708-2

High-volume plasma exchange in patients with acute liver failure: An open randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-016-0708-2

Relevance of ADAMTS13 to liver transplantation and surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-016-0708-2

Treatment of refractory thrombotic thrombocytopenic purpura with N-acetylcysteine: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-016-0708-2

Porto-pulmonary hypertension exacerbated by platelet transfusion in a patient with ADAMTS13 deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-016-0708-2

ADAMTS13 Endopeptidase Protects against Vascular Endothelial Growth Factor Inhibitor-Induced Thrombotic Microangiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-016-0708-2

Acute-on-Chronic Liver Failure Is a Distinct Syndrome That Develops in Patients With Acute Decompensation of Cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-016-0708-2

Von Willebrand factor levels predict clinical outcome in patients with cirrhosis and portal hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-016-0708-2

ADAMTS13 deficiency, despite well-compensated liver functions in patients with noncirrhotic portal hypertension

21 January 2018

1 reference

12 December 2020

Assay of von Willebrand factor (vWF)-cleaving protease based on decreased collagen binding affinity of degraded vWF: a tool for the diagnosis of thrombotic thrombocytopenic purpura (TTP)

1 reference

12 December 2020

An unbalance between von Willebrand factor and ADAMTS13 in acute liver failure: implications for hemostasis and clinical outcome

1 reference

12 December 2020

The hemostatic imbalance of plasma-exchange transfusion

1 reference

12 December 2020

Changes in ADAMTS13 (von-Willebrand-factor-cleaving protease) activity after induced release of von Willebrand factor during acute systemic inflammation

1 reference

12 December 2020

Elevated levels of von Willebrand Factor in cirrhosis support platelet adhesion despite reduced functional capacity

1 reference

12 December 2020

Hepatic and portal vein thrombosis in cirrhosis: possible role in development of parenchymal extinction and portal hypertension

1 reference

12 December 2020

An ELISA test for the binding of von Willebrand antigen to collagen

1 reference

12 December 2020

The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine

1 reference

12 December 2020

Variations in the ratio between von Willebrand factor and its cleaving protease during systemic inflammation and association with severity and prognosis of organ failure.

1 reference

12 December 2020

Treatment and Outcome of Primary and Secondary Thrombotic Microangiopathies

1 reference

12 December 2020

Comprehensive analysis of ADAMTS13 in patients with liver cirrhosis

1 reference

12 December 2020

Active von Willebrand factor predicts 28-day mortality in patients with systemic inflammatory response syndrome

1 reference

12 December 2020

10.1007/S12664-016-0708-2

Identifiers

DOI

1 reference

10 September 2017

1 reference